Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01498991 · ClinicalTrials.gov registry record · Phase 1
Spinal Cord Injury Leg Rehabilitation
A Phase 1 study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT01498991 is a Phase 1 study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 2 participants.
The verdict
NCT01498991, a Phase 1 study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if individuals with incomplete spinal cord injury (SCI) who remain unable to walk normally 1 year after their SCIs are able to sense and move the affected legs better after 10-13 weeks of treatment with a new robotic therapy device. The hypothesis is that using the AMES device on the legs of chronic subjects with incomplete SCI will result in improved strength, sensation in the legs, and improved functional gait in the treated limbs.
Interventions
- DEVICE AMES Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01498991
The ClinicalTrials.gov registry entry for NCT01498991 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AMES Treatment is the first listed.
NCT01498991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01498991 about?
NCT01498991 is a clinical study titled "Spinal Cord Injury Leg Rehabilitation". The purpose of this study is to determine if individuals with incomplete spinal cord injury (SCI) who remain unable to walk normally 1 year after their SCIs are able to sense and move the affected legs better after 10-13 weeks of treatment with a new robotic therapy device. The hypothesis is that u...
What is the current status of trial NCT01498991?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2011-11. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01498991?
The interventions under investigation include: AMES Treatment (DEVICE).
Who is sponsoring clinical trial NCT01498991?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.